Workflow
映恩生物-B(09606.HK)拟发行人民币股份及于上交所科创板上市

Core Viewpoint - The company, InnoCare Pharma-B (09606.HK), announced plans to issue ordinary shares to be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with trading in Renminbi [1] Group 1 - The issuance of shares is subject to market conditions, further approval from the board, shareholder approval at the company's general meeting, and necessary regulatory approvals [1]